
Abbott agrees to consent decree with FDA, could restart plant within 2 weeks, pending court approval
CNN
The baby formula manufacturer at the heart of a nationwide formula recall says it has reached an agreement with the US Food and Drug Administration to enter into a consent decree, a legally binding agreement that would require the company to take certain steps in response to violations found at its Sturgis, Michigan, facility.
If a court approves the agreement, the company says it could restart the site within two weeks. It would first resume the production of its specialty metabolic formulas EleCare and Alimentum, followed by Similac and other formulas.
After Abbott restarts the site, it will take six to eight weeks for the products to reach store shelves, it said.

One year ago this week, Joe Biden was president. I was in Doha, Qatar, negotiating with Israel and Hamas to finalize a ceasefire and hostage release deal. The incoming Trump team worked closely with us, a rare display of nonpartisanship to free hostages and end a war. It feels like a decade ago. A lot can happen in a year, as 2025 has shown.

Botched Epstein redactions trace back to Virgin Islands’ 2020 civil racketeering case against estate
A botched redaction in the Epstein files revealed that government attorneys once accused his lawyers of paying over $400,000 to “young female models and actresses” to cover up his criminal activities

The Justice Department’s leadership asked career prosecutors in Florida Tuesday to volunteer over the “next several days” to help to redact the Epstein files, in the latest internal Trump administrationpush toward releasing the hundreds of thousands of photos, internal memos and other evidence around the late convicted sex offender Jeffrey Epstein.

The US State Department on Tuesday imposed visa sanctions on a former top European Union official and employees of organizations that combat disinformation for alleged censorship – sharply ratcheting up the Trump administration’s fight against European regulations that have impacted digital platforms, far-right politicians and Trump allies, including Elon Musk.









